Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- CheckyesterdayChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check8 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision v3.7.0 was added to the history to reflect a metadata update, and the previous revision v3.6.6 was removed from the visible history.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision label v3.6.6 was added to the study's history and the previous v3.6.5 label was removed. This update affects the revision metadata shown in the record history rather than substantive study content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe history now shows a new revision (v3.6.5) replacing the prior (v3.6.4), indicating an update to the page version in the study's record.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry 'Revision: v3.6.4' has been added to the study history, and the previous 'Revision: v3.6.3' entry is removed from the current listing.SummaryDifference0.1%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.